Preventing contrast-induced nephropathy mainly concerns people with chronic kidney disease, diabetes, heart failure or dehydration who need to undergo angiography. Renal risk assessment, a personalised hydration protocol and a reduction in iodinated contrast are the core measures for making the care pathway safer.
For vascular surgeons, interventional radiologists, nephrologists, general practitioners and hospital management, the goal is to avoid preventable kidney injury without compromising the diagnostic or therapeutic quality of the procedure.
The historical term contrast-induced nephropathy, often abbreviated as CIN, referred to a decline in kidney function after exposure to iodinated contrast. Many guidelines now prefer the term contrast-associated AKI, or CA-AKI: AKI stands for acute kidney injury and describes a rise in creatinine or a reduction in urine output after the procedure, without automatically attributing every case to the contrast medium.
The risk is higher when kidney function is already impaired. eGFR, the estimated glomerular filtration rate, is the most widely used indicator: an eGFR below 30 mL/min/1.73 m² generally identifies the highest-risk group, particularly for intra-arterial procedures. Diabetes, dehydration, hypotension, anaemia, advanced age, sepsis and nephrotoxic drugs also contribute to the overall risk profile.
Hydration with isotonic saline is the preventive measure with the strongest supporting evidence when indicated. It helps maintain adequate renal perfusion and limits the concentration of contrast in the renal tubules. The plan should be defined by the treating team based on eGFR, cardiac function, procedural urgency and fluid balance.
There is no one-size-fits-all protocol. In patients with heart failure, excessive infusion can cause congestion; prevention therefore requires a personalised prescription and, in complex cases, coordination between interventional radiology, vascular surgery, cardiology and nephrology.
Before angiography, it is important to report all medications being taken, including diuretics, non-steroidal anti-inflammatory drugs and treatments for diabetes or hypertension. The doctor will assess whether any temporary changes are needed: patients should not stop medications on their own. Metformin management, for example, depends on kidney function, the route of contrast administration and the presence of AKI.
The evidence does not support the routine use of N-acetylcysteine or sodium bicarbonate as substitutes for isotonic hydration. The randomised PRESERVE trial, published in 2018 and conducted in high-risk patients undergoing angiographic procedures, showed no clinical benefit of bicarbonate over saline, nor of N-acetylcysteine over placebo.
Iodinated contrast is widely used because it provides high-quality images across many applications. However, it is eliminated by the kidneys and calls for particular caution in patients with chronic kidney disease or previous acute kidney injury. CO₂, medical-grade carbon dioxide, is a non-nephrotoxic alternative that can be used mainly for vascular angiography below the diaphragm, as in many peripheral and aorto-iliac procedures.
Within a contrast-sparing pathway, CO₂ can substantially reduce the volume of iodine or, in selected cases, enable CO₂-first or CO₂-only procedures. It is not, however, a universal solution: image quality depends on the vascular territory, technique, patient positioning and the team’s experience. In some situations, a complementary, targeted use of iodine may be needed.
The main benefit of CO₂ is the absence of direct nephrotoxicity and of allergic reactions associated with iodinated contrast. Recent systematic reviews and meta-analyses in peripheral vascular settings indicate a lower incidence of contrast-associated AKI when CO₂ reduces iodine exposure; however, the quality of the evidence remains limited by study heterogeneity and patient selection.
CO₂ requires rigorous protocols, controlled injection and dedicated training. It must not be used for angiography above the diaphragm, including the coronary and cerebral arteries, because of the risk of neurological or cardiac events. Cardiac or pulmonary shunts, pulmonary hypertension and severe respiratory disease require a specific specialist assessment. Nitrous oxide must not be used for sedation during CO₂ injections, as it may increase the risk of gas trapping.
The cost of a procedure is not the same as the price of the contrast medium. A comprehensive hospital assessment considers the device and consumables, training, room time, the volume of iodine avoided, monitoring, complication management, length of stay and potential readmissions. An episode of AKI can increase care complexity and costs, especially in frail patients.
An automated system such as the Angiodroid CO₂ Injector is designed to make CO₂ injection more standardised, traceable and repeatable than manual workflows. Economic sustainability should be verified for each individual centre through a local business case based on case mix, patients with reduced eGFR, iodine volumes and outcome indicators, rather than on generalised promises of savings.
Recommendations from the ESUR (European Society of Urogenital Radiology) and the Canadian Association of Radiologists focus on eGFR-based risk stratification, appropriate indication for the examination, hydration in selected patients and minimisation of the iodine dose. The KDIGO guideline on acute kidney injury remains a reference for identifying and managing AKI.
Recent literature rightly distinguishes between temporal association and causation: not every AKI that appears after an examination is caused by iodinated contrast. This does not diminish the importance of prevention; on the contrary, it points towards more accurate management of modifiable factors such as contrast volume, volume status, haemodynamic instability and the use of non-nephrotoxic alternatives when indicated.
Anyone looking for a centre for safe angiography with kidney failure should check for the presence of interventional radiology or vascular surgery, experience with peripheral procedures, protocols for patients with reduced eGFR and collaboration with nephrology and anaesthesia. Useful local search terms include “CO₂ angiography near me”, “interventional radiology Milan”, “vascular surgery Rome”, “angiography for kidney failure Bologna” or “Zero Contrast centre Naples”.
The key question is not only whether the centre uses CO₂, but whether it offers a complete pathway: patient selection, assessment of contraindications, a certified injector, trained staff, clinical monitoring and documentation of procedural parameters. To discuss the implementation pathway, request an assessment with the Angiodroid team.
How is contrast-induced nephropathy prevented before angiography?
Prevention starts with assessing creatinine, eGFR and clinical factors such as diabetes, dehydration and heart failure. In selected patients, the doctor prescribes hydration with an isotonic solution, limits the volume of iodine and considers contrast-sparing strategies. Do not stop or change medications without your doctor’s instructions.
Is CO₂ angiography safe for people with kidney failure?
CO₂ is not nephrotoxic and is an important option for many vascular angiographies below the diaphragm in people with kidney failure. Safety depends on the indication, the territory treated, the injection technique and individual contraindications. It is not indicated for cerebral or coronary angiography.
What is the difference between CO₂ and iodinated contrast in angiography?
Iodinated contrast provides excellent images but requires caution in patients at high renal risk and in those with specific allergies. CO₂ does not directly damage the kidneys and can reduce or avoid iodine in selected peripheral procedures. The two options can also be combined within a personalised protocol.
Where can I have safe angiography with low eGFR in Italy?
Look for an interventional radiology or vascular surgery centre with experience in patients with kidney disease, AKI prevention protocols and access to nephrology. Search terms such as “CO₂ angiography Milan”, “angiography kidney failure Rome” or “contrast-sparing centre near me” can help you find local facilities. Before booking, ask how the centre manages low eGFR, hydration and iodine reduction.
How much does a CO₂ angiography pathway cost compared with iodine?
The cost depends on the procedure, technology, consumables, training and how the centre is organised. A proper assessment also considers the potential impact of reduced AKI on length of stay, monitoring and readmissions, not just the price of the contrast medium. The centre can provide information on any co-payments, hospital admission and insurance coverage.